Key result
CARE4DIABETES lifestyle intervention reduces HbA1c by ~0.8%, with CGM yielding superior weight loss over SMBG.
Why the study?
Does the addition of continuous glucose monitoring (CGM) to a structured lifestyle intervention improve glycemic and anthropometric outcomes compared to self-monitoring of blood glucose in patients with type 2 diabetes?
Cohort (n=38)
Yes
Does the addition of continuous glucose monitoring (CGM) to a structured lifestyle intervention improve glycemic and anthropometric outcomes compared to self-monitoring of blood glucose in patients with type 2 diabetes?
A structured lifestyle intervention significantly improves glycemic control and anthropometric outcomes in type 2 diabetes, with continuous glucose monitoring providing additional weight loss benefits over self-monitoring of blood glucose.
Type 2 diabetes remains a major public health challenge, requiring lifelong management. Structured lifestyle-based interventions are increasingly recognised for their role in supporting self-management. The CARE4DIABETES (C4D) programme, part of a Joint Action funded by the EU4Health initiative, aims to implement and evaluate a behavioural lifestyle model (Reverse Diabetes2 Now) across 12 European countries. C4D is a 12-month, quasi-experimental, structured, digitally supported lifestyle programme comprising multiple group-based educational sessions delivered by a multidisciplinary team (MDT) and addressing nutrition, physical activity, sleep, and stress management. This interim analysis includes the Polish cohort ( n = 38; type 2 diabetes duration ≤ 10 years), presented overall and stratified by continuous glucose monitoring (CGM) users ( n = 21) versus self-monitoring of blood glucose (SMBG, n = 17). At 6 months, participants showed significant improvements. Mean HbA1c decreased by 0.78% points (–10.9%; p < 0.001) to 6.35%. Body weight decreased by 6.04 kg (–6.5%; p < 0.001), waist circumference by 6.77 cm (–6.4%; p < 0.001), fat mass by 2.47 kg (–7.2%; p < 0.001), and triglycerides by 20.3% ( p = 0.023), while total cholesterol, LDL-C, and HDL-C did not change significantly. Improvements were numerically larger in the CGM group. Between-group comparisons of change scores showed greater reductions in body weight and BMI in the CGM group compared with the SMBG group ( p < 0.05; Cohen’s d ≈ 0.9–1.0). The 6-month intensive phase of this structured, group-based lifestyle education programme was associated with clinically meaningful improvements in glycaemic control and anthropometric outcomes. Improvements were greater among CGM users than in the SMBG group, suggesting that integrating CGM into structured education may further enhance programme outcomes.
No takes yet. Share an insight, caveat, or question.
Ostrowska et al. (2026) conducted a cohort in Type 2 diabetes (n=38). CARE4DIABETES structured lifestyle programme with continuous glucose monitoring (CGM) vs. Self-monitoring of blood glucose (SMBG) was evaluated on Change in HbA1c from baseline to 6 months (decrease of 0.78 percentage points, p=<0.001). The CARE4DIABETES lifestyle programme reduced mean HbA1c by 0.78 percentage points overall, while CGM users had greater reductions in body weight and BMI than SMBG users (p<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: